InvestorsHub Logo
Followers 30
Posts 2777
Boards Moderated 3
Alias Born 10/24/2015

Re: jondoeuk post# 114

Sunday, 04/17/2022 6:05:09 PM

Sunday, April 17, 2022 6:05:09 PM

Post# of 259
They are also working with NKTX on three different products. One will combine CAR-NK plus CAR-T (both could target two different antigens), as well as two CAR-NK cell products, one of which will target CD70 https://crisprtx.gcs-web.com/static-files/83035e80-926a-4e61-b167-bfcde6392ee6
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent CRSP News